CORDIS
EU research results

CORDIS

English EN

Scaling-up of and evidence-based intervention programme in older people with Diabetes and Frailty in LatinAmerica

Project information

Grant agreement ID: 825546

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 991 925

  • EU contribution

    € 3 891 925

Coordinated by:

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.

Spain

Objective

Stemming from the results of three EU-funded projects, DIABFRAIL-LATAM intends to make a scaling up of a multimodal intervention in older people with diabetes very vulnerable because of their frailty status. The scaling up will take place in 5 Latin-American countries (1 HIC and 4 LMICs), in different settings of care. The project embraces three main parts: 1) a validation study (an open Randomized Clinical Trial) that mimics the intervention to be transferred and that was shown to be effective and with a good cost-effective relationship; 2) a feasibility study that will include an economic analysis, adherence assessment and an analysis of the barriers and key factor of success; and 3) a proper scaling up process using a methodology based on the recommendations of the WHO (“WHO ExpandNet model”) and the European Union (“Maturity Model” and “11 success factors” suggested by the Expert Group on Health Systems Performance Assessment) that will take place not only in the five countries participating in the validation of the intervention, but also in other four countries, under the auspices of the Pan-American Health Organization and the cooperation of the local governments.
The consortium of the project is composed by a multidisciplinary team of partners involving academic partners, research partners, clinical partners, public health partners and citizen organizations. In addition, several local, national and international stakeholders, including governmental organizations and NGOs will also provide support in the several settings of care.
The project is clearly aligned with the programs of many of the institutions constituting the Global Alliance for Chronic Diseases (GACD), including the Research&Innovation DG of the European Commission, with projects supported by GACD, with several actions of the EIP-AHA initiative and with strategies on non-communicable chronic conditions in the EU, in several countries of the Latin-American and Caribbean Region, PAHO and WHO.

Coordinator

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.

Address

Calle Monforte De Lemos 5
28029 Madrid

Spain

Activity type

Research Organisations

EU Contribution

€ 1 587 800

Participants (12)

PAN AMERICAN HEALTH ORGANIZATION

United States

EU Contribution

€ 400 000

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italy

EU Contribution

€ 250 000

DIABETES FRAIL LIMITED

United Kingdom

EU Contribution

€ 250 000

UNIVERSIDAD DE CASTILLA - LA MANCHA

Spain

EU Contribution

€ 174 125

CONFEDERACION ESPANOLA DE ORGANIZACIONES DE MAYORES CEOMA

Spain

EU Contribution

€ 150 000

PONTIFICIA UNIVERSIDAD JAVERIANA

Colombia

EU Contribution

€ 220 000

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile

EU Contribution

€ 220 000

INSTITUTO NACIONAL DE GERIATRIA

Mexico

UNIVERSIDAD SAN MARTIN DE PORRES ASOCIACION

Peru

EU Contribution

€ 220 000

CENTRO DE ENDOCRINOLOGIA Y DIABETES DR. RAUL A. GUTMAN SRL

Argentina

EU Contribution

€ 220 000

COLEGIO MAYOR DE NUESTRA SENORA DELROSARIO CORPORACION SIN ANIMO DE LUCRO

Colombia

EU Contribution

€ 100 000

UNIVERSIDAD DE SANTIAGO DE CHILE

Chile

EU Contribution

€ 100 000

Project information

Grant agreement ID: 825546

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 3 991 925

  • EU contribution

    € 3 891 925

Coordinated by:

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.

Spain